Heat Biologics OverviewLatest common stock for HTBX: $12B.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (September 2025), HTBX shows a common stock of $12B. Scroll down for historical charts and peer comparison views.
Tracking HTBX's common stock over time shows whether Heat Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $12B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Heat Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $12B) with ownership activity and broader fundamentals.
Heat Biologics's common stock is $12B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
